Angiotensin receptor blockers (ARBs) vs conventional therapy
Peritonitis · patients receiving PD
Angiotensin receptor blockers (ARBs) showed no clear difference in adverse events (episodes of peritonitis) compared with conventional therapy (low certainty).
1 finding from 1 review
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes onlyRR 0.67 [0.18, 2.54]1 study · 34 participantsLow